Upcoming Mass Tort Cases
COMING SOON
Ozempic and Wegovy Stomach Paralysis Lawsuit
Overview:
GLP-1 receptor agonist drugs, such as Ozempic and Wegovy, prescribed for diabetes and weight loss, are facing increasing scrutiny after reports linked their use to severe gastrointestinal conditions, including gastroparesis (stomach paralysis). Lawsuits are expected to claim that manufacturers failed to adequately warn patients about the long-term side effects.
Current Status:
- Legal teams are currently gathering evidence and preparing to file lawsuits in 2025.
- The case may be consolidated into multidistrict litigation (MDL) soon.
Who May Qualify:
Patients who experienced severe gastrointestinal distress, persistent nausea, or hospitalizations after using these medications.
